Brief: Cantargia Presents Phase 2 Clinical Data In Pancreatic Cancer With Nadunolimab

Cantargia AB

20/06/2024 06:05

June 20 (Reuters) - Cantargia AB  CANTA.ST :
    * CANTARGIA PRESENTS PHASE 2 CLINICAL DATA IN PANCREATIC
CANCER
WITH NADUNOLIMAB AT ESMO GASTROINTESTINAL CANCER CONGRESS 2024
    * CANTARGIA AB - EFFICACY IN 73 PATIENTS TREATED WAS BETTER
THAN
EXPECTED FOR CHEMOTHERAPY ONLY BASED ON HISTORICAL DATA

Source text for Eikon:  ID:nMFN7qTmRr 
Further company coverage:  CANTA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))